Page last updated: 2024-11-13

3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pydiflumetofen: succinate dehydrogenase inhibitor (SDHI) fungicide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pydiflumetofen : A racemate comprising equimolar amounts of (R)- and (S)-pydiflumetofen. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid with the amino group of N-methoxy-1-(2,4,6-trichlorophenyl)propan-2-amine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID56933411
CHEBI ID87576
SCHEMBL ID621538

Synonyms (26)

Synonym
SCHEMBL621538
3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid methoxy-[1-methyl-2-(2,4,6-trichloro-phenyl)-ethyl]amide
3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid methoxy-[1-methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-amide
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide
CHEBI:87576
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl)propan-2-yl]-1h-pyrazole-4-carboxamide
1228284-64-7
whg7i49fak ,
unii-whg7i49fak
3-(difluoromethyl)-n-methoxy-1-methyl-n-(1-methyl-2-(2,4,6-trichlorophenyl)ethyl)-1h-pyrazole-4-carboxamide
1h-pyrazole-4-carboxamide, 3-(difluoromethyl)-n-methoxy-1-methyl-n-(1-methyl-2-(2,4,6-trichlorophenyl)ethyl)-
pydiflumetofen
pydiflumetofen [iso]
3-(difluoromethyl)-n-methoxy-1-methyl-n-((rs)-1-methyl-2-(2,4,6-trichlorophenyl)ethyl)-1h-pyrazole-4-carboxamide
3-(difluoromethyl)-n-methoxy-1-methyl-n-((2.xi.)-1-(2,4,6-trichlorophenyl)propan-2-yl)-1h-pyrazole-4-carboxamide
DTXSID60894826
Q27159744
adepidyn
mfcd31718936
3-(difluoromethyl)-n-methoxy-1-methyl-n-(1-(2,4,6-trichlorophenyl)propan-2-yl)-1h-pyrazole-4-carboxamide
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]-1h-pyrazole-4-carboxamide; 3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl)propan-2-yl]-1h-pyrazole-4-carboxamide; adepidyn; pydiflumetofen
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl) propan-2-yl]pyrazole-4-carboxamide
EN300-6495150
CS-0611991
HY-150127
Z2943875904
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (5)

ClassDescription
trichlorobenzeneAny member of the class of chlorobenzenes carrying three chloro substituents at unspecified positions.
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
aromatic amideAn amide in which the amide linkage is bonded directly to an aromatic system.
pyrazoles
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (5.00)24.3611
2020's19 (95.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.86 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.91 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]